These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 14623518)

  • 1. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.
    Geisler J; Haynes B; Anker G; Dowsett M; Lønning PE
    J Clin Oncol; 2002 Feb; 20(3):751-7. PubMed ID: 11821457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
    Geisler J; Ekse D; Helle H; Duong NK; Lønning PE
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):90-5. PubMed ID: 18242079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue.
    Geisler J; Berntsen H; Lonning PE
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):259-64. PubMed ID: 10822015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
    Folkerd EJ; Dixon JM; Renshaw L; A'Hern RP; Dowsett M
    J Clin Oncol; 2012 Aug; 30(24):2977-80. PubMed ID: 22802308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
    Geisler J; Helle H; Ekse D; Duong NK; Evans DB; Nordbø Y; Aas T; Lønning PE
    Clin Cancer Res; 2008 Oct; 14(19):6330-5. PubMed ID: 18829517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate.
    Lønning PE; Geisler J; Johannessen DC; Ekse D
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):255-60. PubMed ID: 9365198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Lønning PE; Haynes BP; Dowsett M
    Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
    J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.
    Ingle JN; Kalari KR; Buzdar AU; Robson ME; Goetz MP; Desta Z; Barman P; Dudenkov TT; Northfelt DW; Perez EA; Flockhart DA; Williard CV; Wang L; Weinshilboum RM
    Steroids; 2015 Jul; 99(Pt A):32-8. PubMed ID: 25163006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.
    Geisler J; Detre S; Berntsen H; Ottestad L; Lindtjørn B; Dowsett M; Einstein Lønning P
    Clin Cancer Res; 2001 May; 7(5):1230-6. PubMed ID: 11350888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
    Lønning PE; Ekse D
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):409-12. PubMed ID: 8541238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dexaminoglutethimide, an optical isomer of aminoglutethimide, on the disposition of estrone sulfate in postmenopausal breast cancer patients.
    Geisler J; Lundgren S; Berntsen H; Greaves JL; Lønning PE
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2687-93. PubMed ID: 9709932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.
    Dowsett M; Jones A; Johnston SR; Jacobs S; Trunet P; Smith IE
    Clin Cancer Res; 1995 Dec; 1(12):1511-5. PubMed ID: 9815951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
    de Jong PC; van de Ven J; Nortier HW; Maitimu-Smeele I; Donker TH; Thijssen JH; Slee PH; Blankenstein RA
    Cancer Res; 1997 Jun; 57(11):2109-11. PubMed ID: 9187104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.